Community Schedule

Enter at least 4 characters

2 results showing for: 'octreotide'

  • Inj 50 mcg per ml, 1 ml vial
    • Brand Fully subsidised brand. DBL Octreotide
    • Pharmacode2272822
    • Subsidy $56.87
    • Measure / Qty per 5
    • Brand Fully subsidised brand. Octreotide MaxRx Unapproved medicine supplied under Section 29.
    • Pharmacode2396939
    • Subsidy $30.64
    • Measure / Qty per 5
    (DBL Octreotide Inj 50 mcg per ml, 1 ml vial to be delisted 01 June 2022)
    (Octreotide MaxRx Inj 50 mcg per ml, 1 ml vial to be delisted 01 June 2022)
  • Inj 100 mcg per ml, 1 ml vial
    • Brand Fully subsidised brand. DBL Octreotide
    • Pharmacode2272814
    • Subsidy $40.00
    • Measure / Qty per 5
    (DBL Octreotide Inj 100 mcg per ml, 1 ml vial to be delisted 01 June 2022)
  • Inj 500 mcg per ml, 1 ml vial
    • Brand Fully subsidised brand. DBL Octreotide
    • Pharmacode2272806
    • Subsidy $145.00
    • Measure / Qty per 5
    • Brand Fully subsidised brand. Octreotide (Sun) Unapproved medicine supplied under Section 29.
    • Pharmacode2586002
    • Subsidy $222.00
    • Measure / Qty per 5
    (DBL Octreotide Inj 500 mcg per ml, 1 ml vial to be delisted 01 June 2022)
    (Octreotide (Sun) Inj 500 mcg per ml, 1 ml vial to be delisted 01 June 2022)
  • Inj 50 mcg per ml, 1 ml ampoule
    • Brand Fully subsidised brand. Octreotide GH Unapproved medicine supplied under Section 29.
    • Pharmacode2595907
    • Subsidy $30.64
    • Measure / Qty per 5
    • Brand Fully subsidised brand. Max Health
    • Pharmacode2629534
    • Subsidy $27.58
    • Measure / Qty per 5
    Max Health to be Principal Supply on 1 June 2022
    (Octreotide GH Inj 50 mcg per ml, 1 ml ampoule to be delisted 01 June 2022)
  • Inj 100 mcg per ml, 1 ml ampoule
    • Brand Fully subsidised brand. Octreotide GH Unapproved medicine supplied under Section 29.
    • Pharmacode2595885
    • Subsidy $32.71
    • Measure / Qty per 5
    • Brand Fully subsidised brand. Max Health
    • Pharmacode2629518
    • Subsidy $32.71
    • Measure / Qty per 5
    Max Health to be Principal Supply on 1 June 2022
    (Octreotide GH Inj 100 mcg per ml, 1 ml ampoule to be delisted 01 June 2022)
  • Inj 500 mcg per ml, 1 ml ampoule
    • Brand Fully subsidised brand. Octreotide GH Unapproved medicine supplied under Section 29.
    • Pharmacode2595893
    • Subsidy $113.10
    • Measure / Qty per 5
    • Brand Fully subsidised brand. Max Health
    • Pharmacode2629526
    • Subsidy $113.10
    • Measure / Qty per 5
    Max Health to be Principal Supply on 1 June 2022
    (Octreotide GH Inj 500 mcg per ml, 1 ml ampoule to be delisted 01 June 2022)

For GnRH ANALOGUES – refer to HORMONE PREPARATIONS, Trophic Hormones, page 92

- Special Authority SA2119 -- Retail pharmacy
  • Inj depot 10 mg prefilled syringe
    • Brand Fully subsidised brand. Octreotide Depot Teva
    • Pharmacode2615320
    • Subsidy $439.97
    • Measure / Qty per 1
  • Inj depot 20 mg prefilled syringe
    • Brand Fully subsidised brand. Octreotide Depot Teva
    • Pharmacode2615339
    • Subsidy $647.03
    • Measure / Qty per 1
  • Inj depot 30 mg prefilled syringe
    • Brand Fully subsidised brand. Octreotide Depot Teva
    • Pharmacode2615347
    • Subsidy $718.55
    • Measure / Qty per 1
SA2119 – Octreotide long-acting

For GnRH ANALOGUES – refer to HORMONE PREPARATIONS, Trophic Hormones, page 92

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply